NCT00072033View on ClinicalTrials.gov

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

May 31, 2010

Conditions

Esophageal Cancer

Interventions

DRUG

Cisplatin and Docetaxel

cisplatin and docetaxel chemo- and radiochemotherapy

Trial Locations (9)

8063

City Hospital Triemli, Zurich

CH-5001

Kantonspital Aarau, Aarau

CH-4031

Universitaetsspital-Basel, Basel

CH-3010

Inselspital Bern, Bern

CH-7000

Spitaeler Chur AG, Chur

CH-1211

Hopital Cantonal Universitaire de Geneve, Geneva

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

CH-6900

Ospedale Civico, Lugano

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

All Listed Sponsors

lead

Swiss Cancer Institute

OTHER

NCT00072033 - Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer | Biotech Hunter | Biotech Hunter